U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C22H28N.Br
Molecular Weight 386.368
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PRIFINIUM BROMIDE

SMILES

[Br-].CC[N+]1(CC)CCC(C1C)=C(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=UCGJZJXOPSNTGZ-UHFFFAOYSA-M
InChI=1S/C22H28N.BrH/c1-4-23(5-2)17-16-21(18(23)3)22(19-12-8-6-9-13-19)20-14-10-7-11-15-20;/h6-15,18H,4-5,16-17H2,1-3H3;1H/q+1;/p-1

HIDE SMILES / InChI

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C22H28N
Molecular Weight 306.4644
Charge 1
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: description was created based on several sources, including http://www.rlsnet.ru/tn_index_id_6544.htm

Prifinium bromide is antimuscarinic drug, which has antispasmodic, antiemetic effect. Prifinium bromideis approved for pain relief in Russia, Indonesia, Iraq, Tunisia and other countries.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Reyabal

Approved Use

Pain due to spasm and hypermotility of the gastrointestinal tract: gastritis, gastroduodenal ulcer, enteritis, colitis, post-gastrectomy syndrome and irritable colon. Pain due to spasm and dyskinesia of the bile duct cholecystitis, and choleithiasis. Pain due to pancreatitis. Pain due to spasm of urinary tract, lithureteria, vesical tenesmus, cystitis and pyelitis.
Secondary
Reyabal

Approved Use

Premedication for gastric endoscopy and gastrointestinal radiography.
Primary
Riabal

Approved Use

Vomiting (functional spasms in infants and children after feeding, with acute gastroenteritis, febrile conditions, with intracranial hypertension, after radiation therapy, with intolerance of medicines).
PubMed

PubMed

TitleDatePubMed
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
2008 Nov 13
Patents

Sample Use Guides

Tablets of Reyabal, containing 325 mg Paracetamol and 30 mg Prifinium bromide, are indicated against pain 1-2 tablets a day.
Route of Administration: Oral
In Vitro Use Guide
Prifinium bromide depressed the amplitude of muscle contraction induced by electrical stimulation of the phrenic nerve at a concentration of 50 ug/ml, while large concentrations of 100 ug/ml produced no change on muscle contraction induced by direct stimulation of the muscle.
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:16:08 GMT 2023
Edited
by admin
on Sat Dec 16 16:16:08 GMT 2023
Record UNII
3B7O9ZC520
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PRIFINIUM BROMIDE
INN   JAN   MART.   MI   WHO-DD  
INN  
Official Name English
PYRROLIDINIUM, 3-(DIPHENYLMETHYLENE)-1,1-DIETHYL-2-METHYL-, BROMIDE (1:1)
Systematic Name English
PRIFINIUM BROMIDE [MART.]
Common Name English
3-(DIPHENYLMETHYLENE)-1-ETHYL-2-METHYLPYRROLIDINE ETHYL BROMIDE
Systematic Name English
PADRIN
Brand Name English
prifinium bromide [INN]
Common Name English
PRIFINIUM BROMIDE [MI]
Common Name English
PYRROLIDINIUM, 3-(DIPHENYLMETHYLENE)-1,1-DIETHYL-2-METHYL-, BROMIDE
Systematic Name English
Prifinium bromide [WHO-DD]
Common Name English
PDB
Code English
RIABAL
Brand Name English
PRIFINIUM BROMIDE [JAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C66880
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
WHO-ATC A03AB18
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
WHO-VATC QA03AB18
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL1229214
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
ECHA (EC/EINECS)
225-051-8
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
INN
2499
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
MERCK INDEX
m9131
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY Merck Index
DRUG BANK
DBSALT002516
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
SMS_ID
100000081634
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
FDA UNII
3B7O9ZC520
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
WIKIPEDIA
PRIFINIUM BROMIDE
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
RXCUI
9021
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY RxNorm
EPA CompTox
DTXSID3023508
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
CAS
4630-95-9
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
NCI_THESAURUS
C73136
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
MESH
C084641
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
PUBCHEM
20749
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
EVMPD
SUB10039MIG
Created by admin on Sat Dec 16 16:16:08 GMT 2023 , Edited by admin on Sat Dec 16 16:16:08 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY